Safety and Effectiveness of Ciclesonide Nasal Spray in Patients With Perennial Allergic Rhinitis During One Year Treatment (BY9010/M1-404)

Completed · Phase 3

Conditions studied: Perennial Allergic Rhinitis, Allergic Rhinitis, Hay Fever

In brief

The purpose of this study is to investigate the safety and effectiveness of ciclesonide nasal spray as compared with placebo (inactive substance) nasal spray in relieving symptoms of perennial allergic rhinitis.

Key facts

Study ID
NCT00163501
Run by
AstraZeneca
People needed
600
Starts
2003-12-01
Expected to finish
2005-04-01
Last updated by the study team
2016-11-30

Who can join

Age: 12 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.